The cAMP responsive element binding protein 1 transactivates epithelial membrane protein 2, a potential tumor suppressor in the urinary bladder urothelial carcinoma
about
CEBPD amplification and overexpression in urothelial carcinoma: a driver of tumor metastasis indicating adverse prognosis.CSF2 Overexpression Is Associated with STAT5 Phosphorylation and Poor Prognosis in Patients with Urothelial Carcinoma.Necdin Overexpression Predicts Poor Prognosis in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Urinary BladderDownregulation of RNF128 Predicts Progression and Poor Prognosis in Patients with Urothelial Carcinoma of the Upper Tract and Urinary Bladder.Comprehensive analysis of differentially expressed profiles of lncRNAs and circRNAs with associated co-expression and ceRNA networks in bladder carcinoma.The natural dietary genistein boosts bacteriophage-mediated cancer cell killing by improving phage-targeted tumor cell transduction.Silencing of Profilin-1 suppresses cell adhesion and tumor growth via predicted alterations in integrin and Ca2+ signaling in T24M-based bladder cancer modelsDDR2 overexpression in urothelial carcinoma indicates an unfavorable prognosis: a large cohort study.DPP4/CD26 overexpression in urothelial carcinoma confers an independent prognostic impact and correlates with intrinsic biological aggressiveness.MCM10 overexpression implicates adverse prognosis in urothelial carcinoma.CREB1 directly activates the transcription of ribonucleotide reductase small subunit M2 and promotes the aggressiveness of human colorectal cancerPLCB4 copy gain and PLCß4 overexpression in primary gastrointestinal stromal tumors: Integrative characterization of a lipid-catabolizing enzyme associated with worse disease-free survival.Identification of key pathways and genes influencing prognosis in bladder urothelial carcinomaSulfatase-1 overexpression indicates poor prognosis in urothelial carcinoma of the urinary bladder and upper tractMicroRNA-506 inhibits esophageal cancer cell proliferation via targeting CREB1.BCAT1 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder.MicroRNA-122 inhibits proliferation and invasion in gastric cancer by targeting CREB1.
P2860
Q35755517-18A325BA-D1C3-4D66-9655-64EFC9505F30Q35989342-D9DB0501-BDAC-4D81-A84C-918D474CDA67Q36563911-EEBCE3D4-7718-4B44-BAAD-CAF9307B22A4Q37514045-9D84D414-8D7B-4574-A448-E35CD57E408EQ37565087-AEC44908-529A-45D8-88DC-5FFE734FED64Q37588421-979DDB8C-BCA7-4362-9702-44E7A092EC59Q37688606-D4ACDD18-DB3B-45BC-862C-5BEA5F58D13BQ37694728-EF813ECA-9C8A-4B04-BDA5-EFC6BF428994Q37709413-59F0E88E-6797-4C6B-8A07-9E243D16B7ECQ37718437-93C90DBB-B70B-486F-899A-31C1486D3B01Q37718490-8FD4B1D4-EC78-4FB0-B026-F67178040447Q37746218-AA3054AA-B432-4DA0-99EF-3286281B76E2Q38435311-C714B710-30F9-4EC8-8649-E9C742460404Q38774630-D8EF2F52-9F7A-42F3-BEA3-09548A87A163Q38815837-23947EA7-8873-463C-9567-E694FE61C8FCQ40738932-AC96D40E-C497-4CCD-818E-272DCCDDDF29Q42027354-59938047-9372-409C-AC16-2E022D8357C4
P2860
The cAMP responsive element binding protein 1 transactivates epithelial membrane protein 2, a potential tumor suppressor in the urinary bladder urothelial carcinoma
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The cAMP responsive element bi ...... y bladder urothelial carcinoma
@ast
The cAMP responsive element bi ...... y bladder urothelial carcinoma
@en
type
label
The cAMP responsive element bi ...... y bladder urothelial carcinoma
@ast
The cAMP responsive element bi ...... y bladder urothelial carcinoma
@en
prefLabel
The cAMP responsive element bi ...... y bladder urothelial carcinoma
@ast
The cAMP responsive element bi ...... y bladder urothelial carcinoma
@en
P2093
P2860
P356
P1433
P1476
The cAMP responsive element bi ...... y bladder urothelial carcinoma
@en
P2093
Chien-Feng Li
Ching-Chia Li
Chun-Nung Huang
Hsuan-Ying Huang
Lih-Ren Chen
Nan-Haw Chow
Wei-Ming Li
Wen-Jeng Wu
Wen-Ren Wu
Yi-Ling Chen
P2860
P304
P356
10.18632/ONCOTARGET.3312
P407
P577
2015-04-01T00:00:00Z